It will be important to determine whether ERBB3-dependent signaling also contributes in a genetic background-dependent manner to tumorigenesis in other cancers such as breast, lung, and prostate cancers, where PI3K/AKT is also strongly implicated. This evidence concerns the gene AKT1 and prostate cancer.